Novara Mark David

Insider profile

Novara Mark David's trades of Tandem Diabetes Care Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-06-17 2026-06-17 PrS Proposed sale
7,719
274.82
US$2,520,007
7,719 274.82 US$2,520,007
2026-05-19 2026-05-19 PrS Proposed sale
24,503
329.71
US$654,583
24,503 329.71 US$654,583
2026-03-18 2026-03-17 PlS Planned sale
58,772 -24.8%
481.09
US$1,677,001
58,772 -24.8% 481.09 US$1,677,001
2026-03-17 2026-03-17 PrS Proposed sale
187
21.91
US$4,097
187 21.91 US$4,097
2026-03-09 2026-03-05 PlS Planned sale
2 -0.0%
22.81
US$46
2 -0.0% 22.81 US$46
2026-03-05 2026-03-05 PrS Proposed sale
2
23.41
US$47
2 23.41 US$47
2024-11-19 2024-11-15 PP Planned purchase
532 +inf%
23.24
US$12,364
532 +inf% 23.24 US$12,364